Connor, Clark & Lunn Investment Management Ltd. Anika Therapeutics, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 57,606 shares of ANIK stock, worth $934,945. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,606
Previous 58,818
2.06%
Holding current value
$934,945
Previous $1.49 Million
4.5%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ANIK
# of Institutions
123Shares Held
11.5MCall Options Held
200Put Options Held
100-
Trigran Investments, Inc.2.12MShares$34.5 Million5.75% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$26.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA799KShares$13 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX707KShares$11.5 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny574KShares$9.32 Million0.02% of portfolio
About Anika Therapeutics, Inc.
- Ticker ANIK
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,599,900
- Market Cap $237M
- Description
- Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...